Korro Bio, Inc. (KRRO) › Operating IncomeKorro Bio, Inc. (KRRO) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2017: -$16.31M2018: -$18.94M2019: -$20.68M2020: -$27.55M2021: -$84.03M2022: -$59.00M2023: -$84.53M2024: -$91.91M2025: -$121.86M-$121.86M2017Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$121.86M-32.6%2024-$91.91M-8.7%2023-$84.53M-43.3%2022-$59.00M+29.8%2021-$84.03M-205.0%2020-$27.55M-33.3%2019-$20.68M-9.1%2018-$18.94M-16.2%2017-$16.31M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share